Investigation of Cytotoxicity of Biosynthesized Colloidal Nanosilver Against Local : In Vitro Study

Overview

Journal Materials (Basel)

Publisher MDPI

Date 2022 Jul 27

PMID 35888346

Authors

Raghad Zein

Ibrahim Alghoraibi

Chadi Soukkarieh

Abdalrahim Alahmad

Affiliations

Soon will be listed here.

Abstract

Leishmaniasis is one of the biggest health problems in the world. Traditional therapeutic methods still depend on a small range of products, mostly chemically. However, the treatment with these drugs is expensive and can cause serious adverse effects, and they have inconsistent effectiveness due to the resistance of parasites to these drugs. The treatment of leishmanial disease has always been a challenge for researchers. The development of nanoscale metals such as silver has attracted significant attention in the field of medicine. The unique characteristic features of silver nanoparticles (AgNPs) make them effective antileishmanial agents. In recent years, green nanotechnology has provided the development of green nanoparticle-based treatment methods for Leishmaniasis. Although there are many studies based on green nanoparticles against Leishmania parasites, this is the first study on the antileishmanial effect of biosynthesized AgNPs using an aqueous extract of leaves (AEECL) as a reducing agent of silver ions. Different parameters such as AgNO concentration, AEECL concentration, and reaction time were studied to investigate the optimum factors for the preparation of stable and small-sized silver nanoparticles. The spherical shape of colloidal nanosilver (CN-Ag) was confirmed by atomic force microscope (AFM) and scanning electron microscope (SEM) images with sizes of 27 and 12 nm, respectively. A high density of nanoparticles with a small size of 10 nm has been confirmed from dynamic light scattering (DLS) analysis. The zeta potential value of 23 mV indicated that colloidal silver nanoparticles were stable. The nano-tracker analysis (NTA) showed the Brownian motion of silver nanoparticles with a hydrodynamic diameter of 31 nm. The antioxidant property of CN-Ag was determined using the stable radical 2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay. In this study, a significant cytotoxic effect of biosynthesized CN-Ag has been shown against parasites at low concentrations (1.25, 2.5, and 3.75 µg/mL). These results could be used as a future alternative drug or could be a supportive treatment for Leishmaniasis.

Citing Articles

Unlocking the Potential of Silver Nanoparticles: From Synthesis to Versatile Bio-Applications.

Almatroudi A Pharmaceutics. 2024; 16(9).

PMID: 39339268 PMC: 11435049. DOI: 10.3390/pharmaceutics16091232.

Innovating Leishmaniasis Treatment: A Critical Chemist's Review of Inorganic Nanomaterials.

Bessa I, DAmato D, Souza A, Levita D, Mello C, da Silva A ACS Infect Dis. 2024; 10(8):2485-2506.

PMID: 39001837 PMC: 11320585. DOI: 10.1021/acsinfecdis.4c00231.

In vitro evaluation of herbal based Lesh Nat B cream against .

Gul S, Khan M, Amin A, Zaman A, Said A, Iqbal A J Parasit Dis. 2023; 47(3):664-670.

PMID: 37520195 PMC: 10382436. DOI: 10.1007/s12639-023-01611-9.

References

Siddiqi K, Husen A, Rao R . A review on biosynthesis of silver nanoparticles and their biocidal properties. J Nanobiotechnology. 2018; 16(1):14. PMC: 5815253. DOI: 10.1186/s12951-018-0334-5. View

Souto E, Dias-Ferreira J, Craveiro S, Severino P, Sanchez-Lopez E, Garcia M . Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems. Pathogens. 2019; 8(3). PMC: 6789685. DOI: 10.3390/pathogens8030119. View

Akbari M, Oryan A, Hatam G . Application of nanotechnology in treatment of leishmaniasis: A Review. Acta Trop. 2017; 172:86-90. DOI: 10.1016/j.actatropica.2017.04.029. View

Nwabor O, Vongkamjan K, Voravuthikunchai S . Antioxidant Properties and Antibacterial Effects of Ethanolic Leaf Extract on Biofilm Formation, Motility, Hemolysin Production, and Cell Membrane of the Foodborne Pathogen . Foodborne Pathog Dis. 2019; 16(8):581-589. DOI: 10.1089/fpd.2019.2620. View

Kato K, Morais-Teixeira E, Reis P, Silva-Barcellos N, Salaun P, Campos P . Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid. Antimicrob Agents Chemother. 2013; 58(1):481-8. PMC: 3910754. DOI: 10.1128/AAC.01499-13. View

Zein R, Alghoraibi I, Soukkarieh C, Salman A, Alahmad A . In-vitro anticancer activity against Caco-2 cell line of colloidal nano silver synthesized using aqueous extract of leaves. Heliyon. 2020; 6(8):e04594. PMC: 7452526. DOI: 10.1016/j.heliyon.2020.e04594. View

Aleksic Sabo V, Knezevic P . Antimicrobial activity of Dehn. plant extracts and essential oils: A review. Ind Crops Prod. 2020; 132:413-429. PMC: 7126574. DOI: 10.1016/j.indcrop.2019.02.051. View

Ponte-Sucre A, Gamarro F, Dujardin J, Barrett M, Lopez-Velez R, Garcia-Hernandez R . Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis. 2017; 11(12):e0006052. PMC: 5730103. DOI: 10.1371/journal.pntd.0006052. View

Burdusel A, Gherasim O, Grumezescu A, Mogoanta L, Ficai A, Andronescu E . Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview. Nanomaterials (Basel). 2018; 8(9). PMC: 6163202. DOI: 10.3390/nano8090681. View

10.

Ibrahim E, Kilany M, Ghramh H, Khan K, Islam S . Cellular proliferation/cytotoxicity and antimicrobial potentials of green synthesized silver nanoparticles (AgNPs) using . Saudi J Biol Sci. 2019; 26(7):1689-1694. PMC: 6864202. DOI: 10.1016/j.sjbs.2018.08.014. View

11.

Awad M, Al Olayan E, Siddiqui M, Merghani N, Alsaif S, Aloufi A . Antileishmanial effect of silver nanoparticles: Green synthesis, characterization, in vivo and in vitro assessment. Biomed Pharmacother. 2021; 137:111294. DOI: 10.1016/j.biopha.2021.111294. View

12.

El-Khadragy M, Alolayan E, Metwally D, Serag El-Din M, Alobud S, Alsultan N . Clinical Efficacy Associated with Enhanced Antioxidant Enzyme Activities of Silver Nanoparticles Biosynthesized Using Leaf Extract, Against Cutaneous Leishmaniasis in a Murine Model of . Int J Environ Res Public Health. 2018; 15(5). PMC: 5982076. DOI: 10.3390/ijerph15051037. View

13.

Zhang Y, Xu J, Chai Y, Zhang J, Hu Z, Zhou H . Nano-silver modified porcine small intestinal submucosa for the treatment of infected partial-thickness burn wounds. Burns. 2019; 45(4):950-956. DOI: 10.1016/j.burns.2018.12.002. View

14.

Nosratabadi S, Sharifi I, Sharififar F, Bamorovat M, Daneshvar H, Mirzaie M . In vitro antileishmanial activity of methanolic and aqueous extracts of Eucalyptus camaldulensis against Leishmania major. J Parasit Dis. 2015; 39(1):18-21. PMC: 4328029. DOI: 10.1007/s12639-013-0377-3. View

15.

Saleem K, Khursheed Z, Hano C, Anjum I, Anjum S . Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges. Nanomaterials (Basel). 2019; 9(12). PMC: 6955954. DOI: 10.3390/nano9121749. View

16.

Ullah I, Cosar G, Abamor E, Bagirova M, Shinwari Z, Allahverdiyev A . Comparative study on the antileishmanial activities of chemically and biologically synthesized silver nanoparticles (AgNPs). 3 Biotech. 2018; 8(2):98. PMC: 5796947. DOI: 10.1007/s13205-018-1121-6. View

17.

Li F, Jin H, Xiao J, Yin X, Liu X, Li D . The simultaneous loading of catechin and quercetin on chitosan-based nanoparticles as effective antioxidant and antibacterial agent. Food Res Int. 2018; 111:351-360. DOI: 10.1016/j.foodres.2018.05.038. View

18.

Devanesan S, Alsalhi M, Balaji R, Ranjitsingh A, Ahamed A, Alfuraydi A . Antimicrobial and Cytotoxicity Effects of Synthesized Silver Nanoparticles from Punica granatum Peel Extract. Nanoscale Res Lett. 2018; 13(1):315. PMC: 6172160. DOI: 10.1186/s11671-018-2731-y. View

19.

Shu M, He F, Li Z, Zhu X, Ma Y, Zhou Z . Biosynthesis and Antibacterial Activity of Silver Nanoparticles Using Yeast Extract as Reducing and Capping Agents. Nanoscale Res Lett. 2020; 15(1):14. PMC: 6965552. DOI: 10.1186/s11671-019-3244-z. View